ABOUT

Dr. Laura Penny has more than 20 years of experience in creating value for enterprises of many types and sizes through market research, strategic planning, technology evaluation, business modeling, innovation management, and product development across a range of biotechnology applications, including diagnostics, healthcare, medical devices, agriculture, and life science research tools.

 

For over 15 years, she has provided consulting services involving the commercialization of biotechnologies, helping developers and technology users to understand the landscape of existing and emerging technologies, uncover new market opportunities, design differentiated and profitable positions for products, and understand market dynamics surrounding disruptive innovations. 

 

Prior to working as a consultant, she held positions at Pharsight Corporation, Gene Logic, Quintiles and Sequana Therapeutics, and as the Director of the Molecular Diagnostics Laboratory at the University of California, San Diego.  Dr. Penny holds a B.A. in Biochemistry from UC San Diego and a Ph.D. in Human Genetics from Yale University.